Eva Solé

Eva Solé

Auto-generated profile, based on publicly available information

Eva Solé

Perinatal Mental Health Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2017 in CNS Spectrums
Verified
Journal Article
Open access
PDF file
SSStephen Stahl
Stephen Stahl
DMDebbi A. Morrissette
Debbi A. Morrissette
GFGianni Faedda
Gianni Faedda
MFMaurizio Fava
Maurizio Fava
JGJoseph F. Goldberg
Joseph F. Goldberg
RMRoger S. McIntyre
Roger S. McIntyre
A significant minority of people presenting with a major depressive episode (MDE) experience co-occurring subsyndromal hypo/manic symptoms. As this presentation may have important prognostic and treatment implications, the DSM–5 codified a new nosological entity, the “mixed features specifier,” referring to individuals meeting threshold criteria for an MDE and subthreshold symptoms of (hypo)mania or to individuals with syndromal mania and subthreshold depressive symptoms. The mixed features specifier adds to a growing list of monikers that have been put forward to describe phenotypes characterized by the admixture of depressive and hypomanic symptoms (e.g., mixed depression, depression with mixed features, or depressive mixed states [DMX]). Current treatment guidelines, regulatory approvals, as well the current evidentiary base provide insufficient decision support to practitioners who provide care to individuals presenting with an MDE with mixed features. In addition, all existing psychotropic agents evaluated in mixed patients have largely been confined to patient populations meeting the DSM–IV definition of “mixed states” wherein the co-occurrence of threshold-level mania and threshold-level MDE was required. Toward the aim of assisting clinicians providing care to adults with MDE and mixed features, we have assembled a panel of experts on mood disorders to develop these guidelines on the recognition and treatment of mixed depression, based on the few studies that have focused specifically on DMX as well as decades of cumulated clinical experience.

1 January 2020 in American Journal of Psychiatry
Verified
Journal Article
Closed access
MFMichele Fornaro
Michele Fornaro
EMElena Maritan
Elena Maritan
RFRoberta Ferranti
Roberta Ferranti
LZLeonardo Zaninotto
Leonardo Zaninotto
AMAlessandro Miola
Alessandro Miola
MSMarco Solmi
Marco Solmi

29 December 2016 in CNS Spectrums
Verified
Journal Article
Closed access
PDF file
ESEva Solé
Eva Solé
MGMarina Garriga
Marina Garriga
MVMarc Valentí
Marc Valentí
Eduard VietaEduard Vieta
Eduard Vieta
Mixed affective states, defined as the coexistence of depressive and manic symptoms, are complex presentations of manic-depressive illness that represent a challenge for clinicians at the levels of diagnosis, classification, and pharmacological treatment. The evidence shows that patients with bipolar disorder who have manic/hypomanic or depressive episodes with mixed features tend to have a more severe form of bipolar disorder along with a worse course of illness and higher rates of comorbid conditions than those with non-mixed presentations. In the updated Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM–5), the definition of “mixed episode” has been removed, and subthreshold nonoverlapping symptoms of the opposite pole are captured using a “with mixed features” specifier applied to manic, hypomanic, and major depressive episodes. However, the list of symptoms proposed in the DSM–5 specifier has been widely criticized, because it includes typical manic symptoms (such as elevated mood and grandiosity) that are rare among patients with mixed depression, while excluding symptoms (such as irritability, psychomotor agitation, and distractibility) that are frequently reported in these patients. With the new classification, mixed depressive episodes are three times more common in bipolar II compared with unipolar depression, which partly contributes to the increased risk of suicide observed in bipolar depression compared to unipolar depression. Therefore, a specific diagnostic category would imply an increased diagnostic sensitivity, would help to foster early identification of symptoms and ensure specific treatment, as well as play a role in suicide prevention in this population.

1 October 2017 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
MGMarina Garriga
Marina Garriga
ESEva Solé
Eva Solé
AGAna González-Pinto
Ana González-Pinto
GSGabriel Selva-Vera
Gabriel Selva-Vera
BABelén Arranz
Belén Arranz
Eduard VietaEduard Vieta
Eduard Vieta

6 May 2022 in Archives of Women's Mental Health
Verified
Journal Article
Closed access
PDF file
MSMaria Sagué-Vilavella
Maria Sagué-Vilavella
ESEva Solé
Eva Solé
JPJusto Pinzón-Espinosa
Justo Pinzón-Espinosa
ASAna Sandra-Hernández
Ana Sandra-Hernández
EREster Roda
Ester Roda
ARAlba Roca
Alba Roca

1 February 2018 in Journal of Affective Disorders
Verified
Journal Article
Closed access
ITImma Torres
Imma Torres
MGMarina Garriga
Marina Garriga
BSBrisa Sole
Brisa Sole
CBCaterina M. Bonnín
Caterina M. Bonnín
MCMontse Corrales
Montse Corrales
AMAnabel Martinez-Aran
Anabel Martinez-Aran